<SEC-DOCUMENT>0001213900-21-036167-index.html : 20210708
<SEC-HEADER>0001213900-21-036167.hdr.sgml : 20210708
<ACCEPTANCE-DATETIME>20210708160824
ACCESSION NUMBER:		0001213900-21-036167
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		4
CONFORMED PERIOD OF REPORT:	20210706
ITEM INFORMATION:		Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20210708
DATE AS OF CHANGE:		20210708

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Aditxt, Inc.
		CENTRAL INDEX KEY:			0001726711
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				823204328
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39336
		FILM NUMBER:		211080294

	BUSINESS ADDRESS:	
		STREET 1:		737 N. FIFTH STREET, SUITE 200
		CITY:			RICHMOND
		STATE:			VA
		ZIP:			23219
		BUSINESS PHONE:		909-488-0844

	MAIL ADDRESS:	
		STREET 1:		737 N. FIFTH STREET, SUITE 200
		CITY:			RICHMOND
		STATE:			VA
		ZIP:			23219

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Aditx Therapeutics, Inc.
		DATE OF NAME CHANGE:	20201113

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ADiTx Therapeutics, Inc.
		DATE OF NAME CHANGE:	20171229
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>ea143935-8k_aditxt.htm
<DESCRIPTION>CURRENT REPORT
<TEXT>
Document 1 - file: ea143935-8k_aditxt.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.1
<SEQUENCE>2
<FILENAME>ea143935ex3-1_aditxt.htm
<DESCRIPTION>CERTIFICATE OF AMENDMENT, DATED JULY 6, 2021
<TEXT>
Document 2 - file: ea143935ex3-1_aditxt.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>3
<FILENAME>ea143935ex99-1_aditxt.htm
<DESCRIPTION>PRESS RELEASE, DATED JULY 7, 2021
<TEXT>
Document 3 - file: ea143935ex99-1_aditxt.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>ex99-1_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 4 - file: ex99-1_001.jpg

</DOCUMENT>
</SEC-DOCUMENT>